Medical Research and Clinical Trials

Breakthrough in Pediatric Pneumonia Treatment: Early Switch to Oral Antibiotics Proven Safe and Effective, Reducing Hospital Stays

• Medical Research and Clinical Trials

Breakthrough in Pediatric Pneumonia Treatment: Early Switch to Oral Antibiotics Proven Safe and Effective, Reducing Hospital Stays

Basiran July 25, 2026

A groundbreaking clinical trial has demonstrated that children hospitalized with severe pneumonia can safely transition from injectable...

Read More Read more about Breakthrough in Pediatric Pneumonia Treatment: Early Switch to Oral Antibiotics Proven Safe and Effective, Reducing Hospital Stays

Breakthrough in Brain Tumour Diagnosis Promises Rapid Answers and Lifesaving Care

• Medical Research and Clinical Trials

Breakthrough in Brain Tumour Diagnosis Promises Rapid Answers and Lifesaving Care

Asep Darmawan July 24, 2026

Nottingham, UK – A revolutionary new method for genetically diagnosing brain tumours, developed by scientists and clinicians...

Read More Read more about Breakthrough in Brain Tumour Diagnosis Promises Rapid Answers and Lifesaving Care

China Ascends as Oncology Clinical Trial Powerhouse, Reshaping Global Drug Development Landscape

• Medical Research and Clinical Trials

China Ascends as Oncology Clinical Trial Powerhouse, Reshaping Global Drug Development Landscape

Suro Senen July 24, 2026

The once-dominant United States is rapidly ceding ground in the critical field of oncology clinical trials, with...

Read More Read more about China Ascends as Oncology Clinical Trial Powerhouse, Reshaping Global Drug Development Landscape

Unraveling the Silent Threat: Genetics and Treatment Converge in Secondary Cancer Risk for Childhood Cancer Survivors

• Medical Research and Clinical Trials

Unraveling the Silent Threat: Genetics and Treatment Converge in Secondary Cancer Risk for Childhood Cancer Survivors

Layla Zulfa July 24, 2026

Memphis, TN – [Current Date] – A groundbreaking study from St. Jude Children’s Research Hospital has fundamentally...

Read More Read more about Unraveling the Silent Threat: Genetics and Treatment Converge in Secondary Cancer Risk for Childhood Cancer Survivors

A Paradigm Shift in Understanding Tumour Growth: New Research Challenges Decades-Old Beliefs in NF-1

• Medical Research and Clinical Trials

A Paradigm Shift in Understanding Tumour Growth: New Research Challenges Decades-Old Beliefs in NF-1

Evan Lee Salim July 24, 2026

Cambridge, UK – February 25, 2024 – In a significant breakthrough poised to redefine the understanding of...

Read More Read more about A Paradigm Shift in Understanding Tumour Growth: New Research Challenges Decades-Old Beliefs in NF-1

Breakthrough FXI Inhibition: Vortosiran Demonstrates Remarkable Efficacy and Safety in Chronic Coronary Artery Disease Patients

• Medical Research and Clinical Trials

Breakthrough FXI Inhibition: Vortosiran Demonstrates Remarkable Efficacy and Safety in Chronic Coronary Artery Disease Patients

Nana July 24, 2026

Suzhou, China & Shanghai, China – In a significant advancement for the treatment of thromboembolic diseases, Suzhou...

Read More Read more about Breakthrough FXI Inhibition: Vortosiran Demonstrates Remarkable Efficacy and Safety in Chronic Coronary Artery Disease Patients

Paradigm Shift in Cancer Therapy: Scientists Uncover Novel Mechanism for Killing BRCA-Mutant Cells

• Medical Research and Clinical Trials

Paradigm Shift in Cancer Therapy: Scientists Uncover Novel Mechanism for Killing BRCA-Mutant Cells

Raul Delapena Setiawan July 24, 2026

WORCESTER, MA – In a groundbreaking discovery poised to redefine strategies for combating some of the most...

Read More Read more about Paradigm Shift in Cancer Therapy: Scientists Uncover Novel Mechanism for Killing BRCA-Mutant Cells

Arrowhead Pharmaceuticals’ Plozasiran Achieves Landmark Success in Severe Hypertriglyceridaemia Trials, Paving the Way for Novel Treatment

• Medical Research and Clinical Trials

Arrowhead Pharmaceuticals’ Plozasiran Achieves Landmark Success in Severe Hypertriglyceridaemia Trials, Paving the Way for Novel Treatment

Nana Muazin July 24, 2026

San Francisco, CA – July 23, 2026 – Arrowhead Pharmaceuticals has announced groundbreaking top-line results from its...

Read More Read more about Arrowhead Pharmaceuticals’ Plozasiran Achieves Landmark Success in Severe Hypertriglyceridaemia Trials, Paving the Way for Novel Treatment

Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

• Medical Research and Clinical Trials

Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

Nila Kartika Wati July 23, 2026

London, UK – In a significant stride towards revolutionizing cancer treatment, scientists at King’s College London have...

Read More Read more about Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

Eli Lilly’s Retatrutide Achieves Major Milestones in Type 2 Diabetes and Obesity Trials, Paving the Way for Potential Market Dominance

• Medical Research and Clinical Trials

Eli Lilly’s Retatrutide Achieves Major Milestones in Type 2 Diabetes and Obesity Trials, Paving the Way for Potential Market Dominance

Rifan Muazin July 23, 2026

Indianapolis, IN – [Date] – Eli Lilly and Company is poised to further solidify its commanding presence...

Read More Read more about Eli Lilly’s Retatrutide Achieves Major Milestones in Type 2 Diabetes and Obesity Trials, Paving the Way for Potential Market Dominance